These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28218620)

  • 1. Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia.
    Hayes V; Johnston I; Arepally GM; McKenzie SE; Cines DB; Rauova L; Poncz M
    J Clin Invest; 2017 Mar; 127(3):1090-1098. PubMed ID: 28218620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA.
    Reilly MP; Taylor SM; Hartman NK; Arepally GM; Sachais BS; Cines DB; Poncz M; McKenzie SE
    Blood; 2001 Oct; 98(8):2442-7. PubMed ID: 11588041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies.
    Arepally GM; Kamei S; Park KS; Kamei K; Li ZQ; Liu W; Siegel DL; Kisiel W; Cines DB; Poncz M
    Blood; 2000 Mar; 95(5):1533-40. PubMed ID: 10688805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation.
    Johnston I; Sarkar A; Hayes V; Koma GT; Arepally GM; Chen J; Chung DW; López JA; Cines DB; Rauova L; Poncz M
    Blood; 2020 Apr; 135(15):1270-1280. PubMed ID: 32077913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia.
    Kizlik-Masson C; Deveuve Q; Zhou Y; Vayne C; Thibault G; McKenzie SE; Pouplard C; Loyau S; Gruel Y; Rollin J
    Blood; 2019 May; 133(22):2427-2435. PubMed ID: 30917957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
    Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
    J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic?
    Sarkar A; Khandelwal S; Koma GT; Kim H; Gruel Y; Rollin J; Passam F; Wool GD; Arepally GM; Cines DB; Rauova L; Poncz M
    Blood Adv; 2023 Aug; 7(15):4112-4123. PubMed ID: 37196641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia.
    Perdomo J; Leung HHL; Ahmadi Z; Yan F; Chong JJH; Passam FH; Chong BH
    Nat Commun; 2019 Mar; 10(1):1322. PubMed ID: 30899022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications.
    Rauova L; Zhai L; Kowalska MA; Arepally GM; Cines DB; Poncz M
    Blood; 2006 Mar; 107(6):2346-53. PubMed ID: 16304054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TULA-2 (T-Cell Ubiquitin Ligand-2) Inhibits the Platelet Fc Receptor for IgG IIA (FcγRIIA) Signaling Pathway and Heparin-Induced Thrombocytopenia in Mice.
    Zhou Y; Abraham S; Renna S; Edelstein LC; Dangelmaier CA; Tsygankov AY; Kunapuli SP; Bray PF; McKenzie SE
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2315-2323. PubMed ID: 27765766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Strategy to Combat the Procoagulant Phenotype in Heparin-Induced Thrombocytopenia Using 12-LOX Inhibition.
    Renna SA; Zhao X; Kunapuli SP; Ma P; Holinstat M; Boxer MB; Maloney DJ; Michael JV; McKenzie SE
    Arterioscler Thromb Vasc Biol; 2023 Oct; 43(10):1808-1817. PubMed ID: 37345522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia: the role of platelets genetic polymorphisms.
    Pamela S; Anna Maria L; Elena D; Giovanni M; Emanuele A; Silvia V; Carmen B; Andreas G; Fabrizio F
    Platelets; 2013; 24(5):362-8. PubMed ID: 22793995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of monocytes and endothelial cells in heparin-induced thrombocytopenia.
    Madeeva D; Cines DB; Poncz M; Rauova L
    Thromb Haemost; 2016 Oct; 116(5):806-812. PubMed ID: 27487857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia.
    Tutwiler V; Madeeva D; Ahn HS; Andrianova I; Hayes V; Zheng XL; Cines DB; McKenzie SE; Poncz M; Rauova L
    Blood; 2016 Jan; 127(4):464-72. PubMed ID: 26518435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
    Visentin GP; Ford SE; Scott JP; Aster RH
    J Clin Invest; 1994 Jan; 93(1):81-8. PubMed ID: 8282825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic intercellular redistribution of HIT antigen modulates heparin-induced thrombocytopenia.
    Dai J; Madeeva D; Hayes V; Ahn HS; Tutwiler V; Arepally GM; Cines DB; Poncz M; Rauova L
    Blood; 2018 Aug; 132(7):727-734. PubMed ID: 29914979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
    Prechel MM; Jeske WP; Walenga JM
    Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia: new insights into the impact of the FcgammaRIIa-R-H131 polymorphism.
    Carlsson LE; Santoso S; Baurichter G; Kroll H; Papenberg S; Eichler P; Westerdaal NA; Kiefel V; van de Winkel JG; Greinacher A
    Blood; 1998 Sep; 92(5):1526-31. PubMed ID: 9716579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Knowledge about Molecular Mechanisms of Heparin-Induced Thrombocytopenia Type II and Treatment Targets.
    Mongirdienė A; Liuizė A; Kašauskas A
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new approach in the study of the molecular and cellular events implicated in heparin-induced thrombocytopenia. Formation of leukocyte-platelet aggregates.
    Khairy M; Lasne D; Brohard-Bohn B; Aiach M; Rendu F; Bachelot-Loza C
    Thromb Haemost; 2001 Jun; 85(6):1090-6. PubMed ID: 11434690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.